ReviewChemistry (Weinheim an der Bergstrasse, Germany)2026
Tetrazine Ligation in Living Systems: Beyond Fast Kinetics to Effective Bioorthogonality.
Review in Chemistry (Weinheim an der Bergstrasse, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Crystal structures of products from the BBrActa crystallographica. Section E, Crystallographic communications · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Tetrazine-based bioorthogonal chemistry has become a cornerstone of chemical biology due to the exceptional reaction rate and selectivity of the inverse electron-demand Diels-Alder (IEDDA) reaction. These properties have enabled a wide range of applications, from live-cell labeling to in vivo imaging and chemical manipulation of biomolecules. However, accumulating evidence indicates that rapid reaction kinetics alone are insufficient to ensure reliable performance in complex biological environments. In this Review, we examine tetrazine bioorthogonal chemistry from the perspective of effective orthogonality, defined as the ability to react selectively and productively in living systems. We summarize key failure modes that compromise orthogonality in biological settings and discuss emerging design strategies aimed at mitigating these limitations. Building on this framework, we integrate comparative studies that assess tetrazine performance across different levels of biological complexity, highlighting how the dominant constraints on bioorthogonal ligation evolve from cellular to in vivo and compartment-restricted environments. Together, these insights provide a unified perspective on why strategies optimized in simplified systems often fail upon biological translation and offer guidance for the rational development of bioorthogonal reagents for use in living systems.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.